Bioventus Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC BVS

Report date

3/31/2026

Quarter

2026 Q1

Filed

5/13/2026

Shares

736

Value ($000)

7

Weight

0.0%

2021 Q2 - 2026 Q1 (7 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q1	5/13/2026	7	0.0%	736	3/31/2026
2025 Q2	8/14/2025	956	0.0%	144,435	6/30/2025
2025 Q1	5/19/2025	727	0.0%	79,499	3/31/2025
2024 Q4	2/14/2025	684	0.0%	65,155	12/31/2024
2022 Q4	2/14/2023	145	0.0%	55,511	12/31/2022
2021 Q3	11/15/2021	5,502	0.0%	388,533	9/30/2021
2021 Q2	8/16/2021	7,037	0.0%	399,828	6/30/2021